or
forgot password

    • cancer clinical trials in baltimore, MD

    • Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's Sarcoma
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Sarcoma
    Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Greater Baltimore Medical Center Cancer Center
    Lymphoma
    Radiation Therapy, Cyclophosphamide, and Doxorubicin in Treating Women With Stage I or Stage II Breast Cancer Who Have Undergone Surgery
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Breast Cancer
    Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Leukemia, Lymphoma
    Vaccine Therapy in Treating Patients Who Are Being Considered For a Solid Organ Transplant and Are at Risk For Post-Transplant Lymphoproliferative Disorder
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Lymphoproliferative Disorder
    Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Lung Cancer
    Familial Barrett's Esophagus
    Johns Hopkins Hospital
    Baltimore, Maryland 21287
    Barrett's Esophagus, Esophageal Neoplasm
    Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Breast Cancer
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    Johns Hopkins Medical Institute

    Trial Locations
    Johns Hopkins Medical Institute
    Mercy Medical Center
    Melanoma
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    Sinai Hospital of Baltimore
    Baltimore, Maryland 21225
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma
    Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Medical Oncology
    Baltimore, Maryland 21231
    Metastatic Melanoma
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Harry & Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center
    Baltimore, Maryland 21237
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Pancreatic Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Veterans Affairs Medical Center - Baltimore
    Greenebaum Cancer Center at University of Maryland Medical Center
    Greater Baltimore Medical Center Cancer Center
    St. Agnes Hospital Cancer Center
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Franklin Square Hospital Center

    Trial Locations
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    Good Samaritan Hospital of Maryland
    Mercy Medical Center
    The Union Memorial Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231
    Carcinoid, Neuroendocrine
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital

    Trial Locations
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Greenebaum Cancer Center at University of Maryland Medical Center
    Breast Cancer
    Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    Greenbaum Cancer Center

    Trial Locations
    Greenbaum Cancer Center
    The Harry and Jeanette Weinberg Cancer Institute at Franklin
    Breast Cancer
    Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    Greater Baltimore Medical Center
    Melanoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    University of Maryland Greenebaum Cancer Center
    Veterans Administration Medical Center
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    University of Maryland Greenebaum Cancer Center
    Saint Agnes Hospital
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    St. Agnes Hospital Cancer Center
    Osteoporosis, Prostate Cancer